Tender detail
Drug supplies – Rozanolixizumab active substance – ATC L04AL02
Summary
The tender concerns the ongoing supply of medicines containing Rozanolixizumab active substance (ATC L04AL02). The dosage forms offered are 140 mg/ml injectable solution, in packs of 1×2 ml and 1×3 ml, with quantities of 600 and 100 units respectively.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.